Pathogenic and regulatory T cells in type 1 diabetes: Losing self-control, restoring it, and how to take the temperature

Current Diabetes Reports

Volumn 11, Issue 5, 2011, Pages 426-433

  Culina, Slobodan ^a,b   Mallone, Roberto ^a,b,c  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

Author keywords

Epitopes; Innate immunity; Peripheral tolerance; T cell assays; Type 1 diabetes

Indexed keywords

B LYMPHOCYTE ANTIGEN; EPITOPE;

ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE COURSE; EFFECTOR CELL; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE FUNCTION; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REMISSION;

ANIMALS; DIABETES MELLITUS, TYPE 1; EPITOPES; HUMANS; IMMUNITY, INNATE; T-LYMPHOCYTES, REGULATORY;

EID: 80755139679     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-011-0209-8     Document Type: Article

References (55)

1. Arai T, Moriyama H, Shimizu M, et al. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice. Clin Immunol. 2010;136:74-82.
2. Mallone R, Martinuzzi E, Blancou P, et al. CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes. 2007;56:613-21. (Pubitemid 46348452)
3. Skowera A, Ellis RJ, Varela-Calvino R, et al. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest 2008;118:3390-2. This study shows that a PPI epitope derived from the signal peptide is targeted by diabetogenic Tcells and that its processing and presentation by ? cells is regulated by glucose concentrations.
4. Toma A, Laika T, Haddouk S, et al. Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLAA* 0201 transgenic mice and in human type 1 diabetes. Diabetes. 2009;58:394-402.
5. Panina-Bordignon P, Lang R, van Endert PM, et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med. 1995;181:1923-7.
6. Blancou P, Mallone R, Martinuzzi E, et al. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients. J Immunol. 2007;178:7458-66. (Pubitemid 46847474)
7. Winer S, Tsui H, Lau A, Song A, Li X, et al. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med. 2003;9:198-205. (Pubitemid 36227722)
8. Standifer NE, Ouyang Q, Panagiotopoulos C, et al. Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes. 2006;55:3061-7. (Pubitemid 44923643)
9. Lieberman SM, Evans AM, Han B, et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8 + T cells in autoimmune diabetes. Proc Natl Acad Sci USA. 2003;100:8384-8. (Pubitemid 36842554)
10. Dang M, Rockell J, Wagner R, et al. Human Type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol. 2011;186:6056-63
11. Stadinski BD, Delong T, Reisdorph N, et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010;11:225-31. This paper identifies the target epitope of the diabetogenic CD4+ T-cell clone BDC2.5 isolated from NOD mice. This epitope is complexed with I-Ag7 with an unusual binding registry.
12. Mannering SI, Harrison LC, Williamson NA, et al. The insulin Achain epitope recognized by human T cells is posttranslationally modified. J Exp Med. 2005;202:1191-7. (Pubitemid 41586950)
13. Kent SC, Chen Y, Bregoli L, et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature. 2005;435:224-8. (Pubitemid 40685950)
14. McLachlan JB, Catron DM, Moon JJ, Jenkins MK. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity. 2009;30:277-88.
15. Grinberg-Bleyer Y, Saadoun D, Baeyens A, et al. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 2010;120:4558-68. Teffs can boost the expansion and suppressive activity of Tregs, revealing a novel crosstalk pathway in diabetes development and protection.
16. Chen X, Baumel M, Mannel DN, et al. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol. 2007;179: 154-61. (Pubitemid 46986529)
17. Kassiotis G, Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med. 2001;193: 427-34. (Pubitemid 32524474)
18. Liu J, Marino MW, Wong G, et al. TNF is a potent antiinflammatory cytokine in autoimmune-mediated demyelination. Nat Med. 1998;4:78-83. (Pubitemid 28133083)
19. Grinberg-Bleyer Y, Baeyens A, You S, et al. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med 2010;207:1871-8.
20. Chen W, Zhang L, Liang B, et al. Perceiving the avidity of T cell activation can be translated into peripheral T cell regulation. Proc Natl Acad Sci USA. 2007;104:20472-7.
21. Jiang H, Chess L. How the immune system achieves self-nonself discrimination during adaptive immunity. Adv Immunol. 2009;102:95-133.
22. Wu Y, Zheng Z, Jiang Y, et al. The specificity of T cell regulation that enables self-nonself discrimination in the periphery. Proc Natl Acad Sci USA. 2009;106:534-9.
23. Jiang H, Chess L. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu Rev Immunol. 2000;18:185-216. (Pubitemid 30365379)
24. Jiang H, Canfield SM, Gallagher MP, et al. HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest 2010;120:3641-50. This paper provides proof that a human HLAE- restricted CD8+ T-cell subset displays a regulatory role in the periphery and proposes an avidity mechanism of peripheral tolerance that is altered in T1D.
25. Diana J, Brezar V, Beaudoin L, et al. Viral infection prevents diabetes by inducing regulatory T cells through NKT cellplasmacytoid dendritic cell interplay. J Exp Med 2011 208:729-45. The interaction between innate and adaptive immune cells is dissected to explain its opposing role in mounting viral-specific responses and in blunting autoimmunity in mouse models.
26. Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA. 2003;100:8372-7. (Pubitemid 36842552)
27. Tang Q, Henriksen KJ, Bi M, et al. In vitro-expanded antigenspecific regulatory T cells suppress autoimmune diabetes. J Exp Med. 2004;199:1455-65. (Pubitemid 38780401)
28. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24:209-26.
29. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol. 2003;3:253-7. (Pubitemid 37323210)
30. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4 +CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245-53. (Pubitemid 32703119)
31. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057-61. (Pubitemid 36222930)
32. Gavin MA, Rasmussen JP, Fontenot JD, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007;445:771-5. (Pubitemid 46279714)
33. Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29:44-56.
34. Tang Q, Adams JY, Penaranda C, et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 2008;28:687-97.
35. Komatsu N, Mariotti-Ferrandiz ME, Wang Y, et al. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA. 2009;106:1903-8.
36. Zhou X, Bailey-Bucktrout SL, Jeker LT, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009;10:1000-7. This paper supports the notion of plasticity of murine Tregs, which can convert into pathogenic Teffs in vivo.
37. Rubtsov YP, Niec RE, Josefowicz S, et al. Stability of the regulatory T cell lineage in vivo. Science 2010;329:1667-71. At variance with the previous paper, this report contends that murine Tregs display a stable phenotype in vivo.
38. McClymont SA, Putnam AL, Lee MR, et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol. 2011;186:3918-26.
39. Putnam AL, Brusko TM, Lee MR, et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 2009;58:652-62.
40. Floess S, Freyer J, Siewert C, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007;5:e38.
41. Thornton AM, Korty PE, Tran DQ, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymicderived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184:3433-41.
42. Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008;28:29-39.
43. Qin H, Wang Z, Du W, et al. Killer cell Ig-like receptor (KIR) 3DL1 down-regulation enhances inhibition of type 1 diabetes by autoantigen-specific regulatory T cells. Proc Natl Acad Sci USA. 2011;108:2016-21.
44. Verge CF, Stenger D, Bonifacio E, et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes. 1998;47:1857-66. (Pubitemid 28549191)
45. Enee E, Martinuzzi E, Blancou P, et al. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice. J Immunol. 2008;180:5430-8.
46. Willcox A, Richardson SJ, Bone AJ, et al. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009;155:173-81.
47. Mannering SI, Wong FS, Durinovic-Bello I, et al. Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes. Clin Exp Immunol. 2010;162:197-209.
48. Mallone R, Mannering SI, Brooks-Worrell BM, et al. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the TCell Workshop Committee of the Immunology of Diabetes Society. Clin Exp Immunol. 2011;163:33-49.
49. Brooks-Worrell B, Tree T, Mannering SI, et al. Comparison of cryopreservation methods on T cell responses to islet and control antigens from type 1 diabetes patients and controls. Diabetes Metab Res Rev 2011, in press.
50. Seyfert-Margolis V, Gisler TD, Asare AL, et al. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes. 2006;55:2588-94. (Pubitemid 44871160)
51. Herold KC, Brooks-Worrell B, Palmer J, et al. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes. 2009;58:2588-95.
52. Mallone R, Scotto M, Janicki CN, et al. Immunology of Diabetes Society T-cell workshop: HLA class I tetramer-directed epitope validation initiative. Diabetes Metab Res Rev 2011; In press.
53. James EA, Mallone R, Schloot NC, et al. Immunology of Diabetes Society T-cell workshop: HLA class II tetramer-directed epitope validation initiative. Diabetes Metab Res Rev 2011; In press.
54. Fourlanos S, Perry C, Gellert SA, et al. Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes. Diabetes 2011;60:1237-45. This paper is the first to document Ag-specific tolerance restoration both at the T-cell and antibody level following intranasal insulin administration in T1D patients.
55. Martinuzzi E, Afonso G, Gagnerault MC, et al. Accelerated cocultured dendritic cells (acDCs) enhance human antigen-specific T-cell responses. Blood 2011; doi:10.1182/blood-2010-12-326231